These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 7631155)
1. Mechanisms by which the I-ABM12 mutation influences susceptibility to experimental myasthenia gravis: a study in homozygous and heterozygous mice. Karachunski PI; Ostlie N; Bellone M; Infante AJ; Conti-Fine BM Scand J Immunol; 1995 Aug; 42(2):215-25. PubMed ID: 7631155 [TBL] [Abstract][Full Text] [Related]
2. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor. Bellone M; Ostlie N; Lei SJ; Wu XD; Conti-Tronconi BM J Immunol; 1991 Sep; 147(5):1484-91. PubMed ID: 1715360 [TBL] [Abstract][Full Text] [Related]
3. Effect of amino acid substitutions within the region 62-76 of I-A beta b on binding with and antigen presentation of Torpedo acetylcholine receptor alpha-chain peptide 146-162. Oshima M; Atassi MZ J Immunol; 1995 May; 154(10):5245-54. PubMed ID: 7537303 [TBL] [Abstract][Full Text] [Related]
4. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes. Infante AJ; Thompson PA; Krolick KA; Wall KA J Immunol; 1991 May; 146(9):2977-82. PubMed ID: 1707927 [TBL] [Abstract][Full Text] [Related]
5. Preferential use of a T cell receptor V beta gene by acetylcholine receptor reactive T cells from myasthenia gravis-susceptible mice. Infante AJ; Levcovitz H; Gordon V; Wall KA; Thompson PA; Krolick KA J Immunol; 1992 Jun; 148(11):3385-90. PubMed ID: 1375242 [TBL] [Abstract][Full Text] [Related]
6. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope. Atassi MZ; Oshima M; Deitiker P Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597 [TBL] [Abstract][Full Text] [Related]
7. T cell responses in EAMG-susceptible and non-susceptible mouse strains after immunization with overlapping peptides encompassing the extracellular part of Torpedo californica acetylcholine receptor alpha chain. Implication to role in myasthenia gravis of autoimmune T-cell responses against receptor degradation products. Oshima M; Yokoi T; Deitiker P; Atassi MZ Autoimmunity; 1998; 27(2):79-90. PubMed ID: 9583739 [TBL] [Abstract][Full Text] [Related]
8. Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences. Karachunski PI; Ostlie NS; Okita DK; Conti-Fine BM J Clin Invest; 1997 Dec; 100(12):3027-35. PubMed ID: 9399949 [TBL] [Abstract][Full Text] [Related]
9. Residues within the alpha subunit sequence 304-322 of muscle acetylcholine receptor forming autoimmune CD4+ epitopes in BALB/c mice. Karachunski PI; Ostlie N; Conti-Tronconi BM; Bellone M Immunology; 1994 May; 82(1):22-7. PubMed ID: 7519170 [TBL] [Abstract][Full Text] [Related]
10. How subtle differences in MHC class II affect the severity of experimental myasthenia gravis. Yang B; McIntosh KR; Drachman DB Clin Immunol Immunopathol; 1998 Jan; 86(1):45-58. PubMed ID: 9434796 [TBL] [Abstract][Full Text] [Related]
11. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptor. Shenoy M; Oshima M; Atassi MZ; Christadoss P Clin Immunol Immunopathol; 1993 Mar; 66(3):230-8. PubMed ID: 7679342 [TBL] [Abstract][Full Text] [Related]
12. Factors that determine the severity of experimental myasthenia gravis. Drachman DB; McIntosh KR; Yang B Ann N Y Acad Sci; 1998 May; 841():262-82. PubMed ID: 9668247 [TBL] [Abstract][Full Text] [Related]
13. T helper function of CD4+ cells specific for defined epitopes on the acetylcholine receptor in congenic mouse strains. Bellone M; Ostlie N; Lei S; Manfredi AA; Conti-Tronconi BM J Autoimmun; 1992 Feb; 5(1):27-46. PubMed ID: 1373061 [TBL] [Abstract][Full Text] [Related]
14. Absence of IL-4 facilitates the development of chronic autoimmune myasthenia gravis in C57BL/6 mice. Ostlie N; Milani M; Wang W; Okita D; Conti-Fine BM J Immunol; 2003 Jan; 170(1):604-12. PubMed ID: 12496449 [TBL] [Abstract][Full Text] [Related]
15. Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the alpha subunits of Torpedo californica and murine acetylcholine receptors. Bellone M; Ostlie N; Lei S; Conti-Tronconi BM Eur J Immunol; 1991 Oct; 21(10):2303-10. PubMed ID: 1680694 [TBL] [Abstract][Full Text] [Related]
16. Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice. Karachunski PI; Ostlie NS; Monfardini C; Conti-Fine BM J Immunol; 2000 May; 164(10):5236-44. PubMed ID: 10799884 [TBL] [Abstract][Full Text] [Related]
17. Cryptic epitopes on the nicotinic acetylcholine receptor are recognized by autoreactive CD4+ cells. Bellone M; Ostlie N; Karachunski P; Manfredi AA; Conti-Tronconi BM J Immunol; 1993 Jul; 151(2):1025-38. PubMed ID: 7687612 [TBL] [Abstract][Full Text] [Related]
18. Highly conserved TCR beta chain CDR3 sequences among immunodominant acetylcholine receptor-reactive T cells in murine myasthenia gravis. Pierce JL; Zborowski KA; Kraig E; Infante AJ Int Immunol; 1994 May; 6(5):775-83. PubMed ID: 8080845 [TBL] [Abstract][Full Text] [Related]
19. Autoimmune responses against acetylcholine receptor: T and B cell collaboration and manipulation by synthetic peptides. Atassi MZ; Oshima M Crit Rev Immunol; 1997; 17(5-6):481-95. PubMed ID: 9419435 [TBL] [Abstract][Full Text] [Related]
20. T cell receptor transgenic mice recognizing the immunodominant epitope of the Torpedo californica acetylcholine receptor. Lobito AA; Yang B; Lopes MF; Miagkov A; Adams RN; Palardy GR; Johnson MM; McFarland HI; Recher M; Drachman DB; Lenardo MJ Eur J Immunol; 2002 Jul; 32(7):2055-67. PubMed ID: 12115627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]